chrX-154398551-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006013.5(RPL10):c.23+9T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00433 in 1,209,684 control chromosomes in the GnomAD database, including 154 homozygotes. There are 1,507 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0053 ( 12 hom., 196 hem., cov: 24)
Exomes 𝑓: 0.0042 ( 142 hom. 1311 hem. )
Consequence
RPL10
NM_006013.5 intron
NM_006013.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.974
Genes affected
RPL10 (HGNC:10298): (ribosomal protein L10) This gene encodes a ribosomal protein that is a component of the 60S ribosome subunit. The related protein in chicken can bind to c-Jun and can repress c-Jun-mediated transcriptional activation. Some studies have detected an association between variation in this gene and autism spectrum disorders, though others do not detect this relationship. There are multiple pseudogenes of this gene dispersed throughout the genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant X-154398551-T-A is Benign according to our data. Variant chrX-154398551-T-A is described in ClinVar as [Benign]. Clinvar id is 130161.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0744 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL10 | NM_006013.5 | c.23+9T>A | intron_variant | ENST00000369817.7 | NP_006004.3 | |||
LOC124905228 | XR_007068356.1 | n.292A>T | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPL10 | ENST00000369817.7 | c.23+9T>A | intron_variant | 5 | NM_006013.5 | ENSP00000358832 | P1 | |||
ENST00000624054.2 | n.292A>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.00524 AC: 589AN: 112384Hom.: 11 Cov.: 24 AF XY: 0.00562 AC XY: 194AN XY: 34528
GnomAD3 genomes
AF:
AC:
589
AN:
112384
Hom.:
Cov.:
24
AF XY:
AC XY:
194
AN XY:
34528
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0156 AC: 2862AN: 183045Hom.: 104 AF XY: 0.0113 AC XY: 762AN XY: 67531
GnomAD3 exomes
AF:
AC:
2862
AN:
183045
Hom.:
AF XY:
AC XY:
762
AN XY:
67531
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00423 AC: 4645AN: 1097246Hom.: 142 Cov.: 30 AF XY: 0.00361 AC XY: 1311AN XY: 362818
GnomAD4 exome
AF:
AC:
4645
AN:
1097246
Hom.:
Cov.:
30
AF XY:
AC XY:
1311
AN XY:
362818
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00532 AC: 598AN: 112438Hom.: 12 Cov.: 24 AF XY: 0.00567 AC XY: 196AN XY: 34592
GnomAD4 genome
AF:
AC:
598
AN:
112438
Hom.:
Cov.:
24
AF XY:
AC XY:
196
AN XY:
34592
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 12, 2015 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at